OpenAI

OpenAI CEO Altman's role as co-chair signals tech-driven approaches to municipal challenges, potentially bringing innovation to governance.

OpenAI partners with Sanofi, Simplon, Mirakl & ESCP in France, focusing on clinical trials, education, marketplace growth & personalised learning.

Company created 240 custom GPTs in 10 weeks, including specialised tools for fragrance analysis and clinical trials, achieving 90% faster response times.

Models combining web search with LLMs outperformed standalone models on SimpleQA. Real-time data access proved crucial for factual accuracy.

"As election results loom, xAI's $15.4B in government contracts and stance on AI bias reflects deepening ideological divisions in Silicon Valley's AI landscape."

"The search uses fine-tuned GPT-4 with novel synthetic data generation. Users can trigger web searches automatically or manually, with linked source citations."